Diabetic Retinopathy and NADPH Oxidase-2: A Sweet Slippery Road

Kowluru, Renu A. (2021) Diabetic Retinopathy and NADPH Oxidase-2: A Sweet Slippery Road. Antioxidants, 10 (5). p. 783. ISSN 2076-3921

[thumbnail of antioxidants-10-00783.pdf] Text
antioxidants-10-00783.pdf - Published Version

Download (860kB)

Abstract

Diabetic retinopathy remains the leading cause of vision loss in working-age adults. The multi-factorial nature of the disease, along with the complex structure of the retina, have hindered in elucidating the exact molecular mechanism(s) of this blinding disease. Oxidative stress appears to play a significant role in its development and experimental models have shown that an increase in cytosolic Reacttive Oxygen Speies (ROS) due to the activation of NADPH oxidase 2 (Nox2), is an early event, which damages the mitochondria, accelerating loss of capillary cells. One of the integral proteins in the assembly of Nox2 holoenzyme, Rac1, is also activated in diabetes, and due to epigenetic modifications its gene transcripts are upregulated. Moreover, addition of hyperlipidemia in a hyperglycemic milieu (type 2 diabetes) further exacerbates Rac1-Nox2-ROS activation, and with time, this accelerates and worsens the mitochondrial damage, ultimately leading to the accelerated capillary cell loss and the development of diabetic retinopathy. Nox2, a multicomponent enzyme, is a good candidate to target for therapeutic interventions, and the inhibitors of Nox2 and Rac1 (and its regulators) are in experimental or clinical trials for other diseases; their possible use to prevent/halt retinopathy will be a welcoming sign for diabetic patients.

Item Type: Article
Subjects: Middle East Library > Agricultural and Food Science
Depositing User: Unnamed user with email support@middle-eastlibrary.com
Date Deposited: 23 May 2024 07:23
Last Modified: 23 May 2024 07:23
URI: http://editor.openaccessbook.com/id/eprint/1334

Actions (login required)

View Item
View Item